Share-based Compensation Plans (Tables)

6 Months Ended

Jun. 30, 2022

The following table summarizes the impact of the Company’s share-based payment plans in the financial statements for the period shown:


	Six Months Ended
	June 30,
	2022		2021
Total cost of stock grant plan during the year	$	134	$	102
Total cost of stock option plan during the year		94		80
Total cost of share-based payment plans during the year	$	228	$	182

Amount of related income tax benefit recognized in income	$	56	$	43

The following tables summarize stock options activity for the six months ended June 30, 2022 and 2021:


	Outstanding
				Weighted
		Weighted		Average	Aggregate
		Average		Remaining	Intrinsic
	Stock Option	Exercise		Contractual	Value
	Awards	Price		Term (years)	(in dollars)
Options outstanding as of December 31, 2021	316,875	$	10.73
Granted	27,000		12.16
Exercised	—		—
Expired or cancelled	—		—
Forfeited	—		—
Options outstanding as of June 30, 2022	343,875	$	10.84	7.17	$	450,040
Options exercisable as of June 30, 2022	152,482	$	10.69	6.86	$	220,867



				Weighted
		Weighted		Average	Aggregate
		Average		Remaining	Intrinsic
	Stock Option	Exercise		Contractual	Value
	Awards	Price		Term (years)	(in dollars)
Options outstanding as of December 31, 2020	269,220	$	10.51
Granted	76,000		11.27
Exercised	—		—
Expired or canceled	—		—
Forfeited	(19,057)		10.01
Options outstanding as of June 30, 2021	326,163	$	10.72	8.00	$	207,476
Options exercisable as of June 30, 2021	134,066	$	10.80	7.50	$	63,140

The following is a summary of changes in restricted shares for the six months ended June 30, 2022 and 2021:


		Weighted
		Average
	Number of	Grant Date Fair
	Shares	Value
Nonvested stock awards as of December 31, 2021	59,737	$	11.02
Granted	17,500		11.25
Vested	(8,323)		11.16
Forfeited	—		—
Nonvested stock awards as of June 30, 2022	68,914	$	11.06

Nonvested stock awards as of December 31, 2020	62,060	$	10.73
Granted	19,750		11.25
Vested	(19,561)		10.77
Forfeited	(5,519)		10.08
Nonvested stock awards as of June 30, 2021	56,730	$	10.97

FFBW, Inc. /MD/ 10-Q